US 8927576
HCV inhibitor and therapeutic agent combinations
granted A61PA61P31/14
Quick answer
US patent 8927576 (HCV inhibitor and therapeutic agent combinations) held by PTC THERAPEUTICS, INC. expires Mon Jan 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- PTC THERAPEUTICS, INC.
- Grant date
- Tue Jan 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61P, A61P31/14